Candida albicans Epithelial Cell Interactions and Oropharyngeal Disease
白色念珠菌上皮细胞相互作用与口咽疾病
基本信息
- 批准号:8469749
- 负责人:
- 金额:$ 33.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-08-01 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeAntifungal AgentsAzole resistanceAzolesBindingCandida albicansCell CommunicationCell Surface ProteinsCell WallCell surfaceCharacteristicsChitinaseComplexDataDefectDevelopmentDiabetes MellitusDiseaseE-CadherinEndocytosisEpithelial CellsFoundationsFundingGene TargetingGenesGoalsGrantHIVHead and Neck CancerHexose TransporterHighly Active Antiretroviral TherapyHost Defense MechanismImmuneImmunocompromised HostImmunosuppressionIn VitroIncidenceIndividualInvadedMediatingMicroarray AnalysisMorbidity - disease rateMusNeutropeniaOpportunistic InfectionsOralOrganismOropharyngealPathogenesisPathogenicityPatientsPhosphotransferasesPlayPopulation HeterogeneityPublic HealthReceptor CellReceptor Protein-Tyrosine KinasesResearchRoleSignal Transduction PathwaySjogren&aposs SyndromeSpecific qualifier valueSteroidsTherapeuticVirulenceWorkbasecell injurycomplement 1q receptorhuman PHEMX proteininsightmeetingsmouse modelmutantnew therapeutic targetnovel strategiesnovel therapeuticsoropharyngeal thrushoverexpressionpathogenpatient populationpreventpublic health relevancereceptor binding
项目摘要
DESCRIPTION (provided by applicant): Candida albicans is an opportunistic pathogen that causes oropharyngeal disease in a large and diverse population of patients, including those with HIV/AIDS, Sjogren's syndrome, diabetes mellitus, and cancer of the head and neck. Azole antifungal agents are the current mainstay of therapy for oropharyngeal candidiasis. However, because of the emergence of azole resistance, it is critical to develop novel strategies to prevent and treat this disease. Our goal is to identify new C. albicans virulence genes and to determine the mechanisms by which they contribute to pathogenicity. This information holds promise to identify new therapeutic targets for antifungal strategies. C. albicans invades oral epithelial cells by inducing its own endocytosis. In the previous project period, we discovered that C. albicans Als3 is an invasin that binds to E-cadherin on the epithelial cell surface and induces the endocytosis of the organism. Recently, we have determined that there are additional epithelial cell surface proteins that mediate endocytosis. These epithelial cell surface proteins include the globular C1q receptor (gC1qR) and the Met receptor tyrosine kinase. Also, the tetraspanin, CD151 likely organizes E-cadherin, gC1qR, and Met into a functional complex. We have also discovered that the C. albicans kinase, Tpk2 governs the capacity of C. albicans to invade and damage oral epithelial cells in vitro, as well as cause oropharyngeal candidiasis in mice. Further, Tpk2 governs the expression of the C. albicans chitinase, Cht2 and hexose transporter, Hgt12, which play key roles in C. albicans interaction with epithelial cells. In this project, we will 1) determine the functional interactions among E-cadherin, gC1qR, Met, and CD151 in epithelial cell invasion and damage by C. albicans; 2) determine the mechanisms by which C. albicans Cht2 and Hgt12 govern epithelial cell invasion, damage, and virulence; and 3) use overexpression-rescue and null mutant analysis to identify additional target genes of Tpk2 that mediate epithelial cell invasion and damage.
描述(由申请方提供):白色念珠菌是一种机会致病菌,可导致大量不同人群的口咽疾病,包括HIV/AIDS、干燥综合征、糖尿病和头颈癌患者。唑类抗真菌药物是目前治疗口咽念珠菌病的主要药物。然而,由于唑类耐药性的出现,开发新的策略来预防和治疗这种疾病至关重要。我们的目标是确定新的C。白念珠菌毒力基因,并确定其致病机制。这一信息有望确定新的抗真菌策略的治疗靶点。 C.白色念珠菌通过诱导其自身的内吞作用侵入口腔上皮细胞。在上一个项目期间,我们发现C。白色念珠菌Als 3是一种侵袭素,其结合上皮细胞表面上的E-钙粘蛋白并诱导生物体的内吞作用。最近,我们已经确定,有额外的上皮细胞表面蛋白介导的内吞作用。这些上皮细胞表面蛋白包括球状C1 q受体(gC 1 qR)和Met受体酪氨酸激酶。此外,四跨膜蛋白CD 151可能将E-钙粘蛋白、gC 1 qR和Met组织成功能复合物。我们还发现C.白念珠菌激酶Tpk 2控制着白念珠菌的能力。白念珠菌在体外侵袭和破坏口腔上皮细胞,以及在小鼠中引起口咽念珠菌病。此外,Tpk 2控制C.白念珠菌几丁质酶Cht 2和己糖转运蛋白Hgt 12在白念珠菌中起关键作用。白色念珠菌与上皮细胞的相互作用。本研究的目的是:1)探讨E-钙粘蛋白、gC 1 qR、Met和CD 151在大肠杆菌侵袭和损伤上皮细胞中的相互作用; 2)确定C.白色念珠菌Cht 2和Hgt 12控制上皮细胞侵袭、损伤和毒力;和3)使用过表达拯救和无效突变分析来鉴定介导上皮细胞侵袭和损伤的Tpk 2的另外的靶基因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scott G Filler其他文献
Scott G Filler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scott G Filler', 18)}}的其他基金
Epigenomic Mechanisms & STAT Networks in Persistent CA Candidemia
表观基因组机制
- 批准号:
10551709 - 财政年份:2023
- 资助金额:
$ 33.47万 - 项目类别:
Transcriptional networks governing A. fumigatus virulence
控制烟曲霉毒力的转录网络
- 批准号:
10365846 - 财政年份:2021
- 资助金额:
$ 33.47万 - 项目类别:
Transcriptional networks governing A. fumigatus virulence
控制烟曲霉毒力的转录网络
- 批准号:
10687125 - 财政年份:2021
- 资助金额:
$ 33.47万 - 项目类别:
C. albicans invasion and proliferation during oral infection
口腔感染期间白色念珠菌的侵袭和增殖
- 批准号:
9894647 - 财政年份:2017
- 资助金额:
$ 33.47万 - 项目类别:
11th ASM Conference on Candida and candidiasis
第 11 届 ASM 念珠菌和念珠菌病会议
- 批准号:
8257412 - 财政年份:2012
- 资助金额:
$ 33.47万 - 项目类别:
TRANSCRIPTIONAL REGULATION OF A FUMIGATUS VIRULENCE
烟菌毒力的转录调控
- 批准号:
8174490 - 财政年份:2009
- 资助金额:
$ 33.47万 - 项目类别:
CLINICAL TRIAL: INVASIVE ASPERGILLOSIS DIAGNOSIS AND PATHOGENESIS
临床试验:侵袭性曲霉病的诊断和发病机制
- 批准号:
8174531 - 财政年份:2009
- 资助金额:
$ 33.47万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 33.47万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 33.47万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 33.47万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 33.47万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 33.47万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 33.47万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 33.47万 - 项目类别:














{{item.name}}会员




